drugset / Trial / NCT00856752

Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and Cyclosporine

NCT00856752

Phase 1 Completed 12 enrolled Norgine
RandomizedCrossoverOpen-labelDiagnostic

Summary

A study in healthy volunteers to determine whether different drugs metabolised by the liver have any effects on how NRL972 is processed within the body.

Timeline

Start
2006-06
Primary completion
2006-07
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject FLUORESCEIN LISICOL Diagnostic / imaging agent 2 mg Intravenous

Indications

No indication recorded.